Hedge Fund - Partner Fund Management
Arcus Biosciences Inc. (RCUS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $15.98 |
| 2 | 2023 - Q3 (2023-09-30) | $25,220,755 | 1.18% | 1,405,056 | $20.09 |
| 3 | 2023 - Q2 (2023-06-30) | $28,536,687 | 1.1% | 1,405,056 | $19.04 |
| 4 | 2023 - Q1 (2023-03-31) | $28,453,433 | 1.25% | 1,559,947 | $19.11 |
| 5 | 2022 - Q4 (2022-12-31) | $55,903,975 | 2% | 2,703,287 | $27.52 |
| 6 | 2022 - Q3 (2022-09-30) | $88,505,000 | 3.2% | 3,383,233 | $26.45 |
| 7 | 2022 - Q2 (2022-06-30) | $84,799,000 | 3.23% | 3,346,458 | $24.49 |
| 8 | 2022 - Q1 (2022-03-31) | $108,283,000 | 4.04% | 3,431,010 | $33.51 |
| 9 | 2021 - Q4 (2021-12-31) | $138,853,000 | 4.72% | 3,431,010 | $38.79 |
| 10 | 2021 - Q3 (2021-09-30) | $119,639,000 | 3.51% | 3,431,010 | $31.12 |
| 11 | 2021 - Q2 (2021-06-30) | $96,062,000 | 3.01% | 3,498,260 | $28.56 |
| 12 | 2021 - Q1 (2021-03-31) | $98,231,000 | 2.99% | 3,498,260 | $34.80 |
| 13 | 2020 - Q4 (2020-12-31) | $87,575,000 | 3.08% | 3,373,460 | $24.20 |
| 14 | 2020 - Q3 (2020-09-30) | $43,483,000 | 2.01% | 2,536,932 | $22.34 |
| 15 | 2020 - Q2 (2020-06-30) | $42,938,000 | 2.22% | 1,735,581 | $26.99 |
| 16 | 2020 - Q1 (2020-03-31) | $11,236,000 | 0.92% | 809,511 | $12.44 |
| 17 | 2019 - Q1 (2019-03-31) | $0 | 0% | 0 | $10.85 |
| 18 | 2018 - Q4 (2018-12-31) | $2,380,000 | 0.06% | 220,976 | $11.67 |
| 19 | 2018 - Q3 (2018-09-30) | $10,090,000 | 0.14% | 723,834 | $12.75 |
| 20 | 2018 - Q2 (2018-06-30) | $9,404,000 | 0.14% | 768,279 | $15.69 |
| 21 | 2018 - Q1 (2018-03-31) | $14,410,000 | 0.29% | 933,286 | $16.66 |
The displayed share prices are average quarterly stock market prices.